Company Filing History:
Years Active: 2022
Title: The Innovations of Sujuan Chen
Introduction
Sujuan Chen is a prominent inventor based in Yangzhou, China. She has made significant contributions to the field of avian influenza research. Her work focuses on developing vaccines that can effectively combat the H7N9 subtype of avian influenza virus.
Latest Patents
Sujuan Chen holds a patent for a recombinant H7N9 subtype avian influenza virus, inactivated marked vaccine, and its preparation method. This innovative vaccine utilizes a strain JD/17 of the H7N9 subtype avian influenza virus as the parent virus. The invention involves replacing a peptide sequence in the HA protein of the strain JD/17 with a peptide sequence from the HA protein of the H3 subtype. The strain JD/17 has a preservation number of CCTCC No. V201862. The results indicate that the rescued virus maintains similar biological characteristics to the parent virus, such as high HA titers and EID50. Chickens immunized with the marked inactivated and emulsified vaccine produce a high level of antibodies, which can be distinguished from those produced by chickens naturally infected with the H7N9 subtype avian influenza virus.
Career Highlights
Sujuan Chen is affiliated with Yangzhou University, where she conducts her research and development work. Her dedication to advancing vaccine technology has positioned her as a key figure in her field.
Collaborations
Sujuan Chen collaborates with notable colleagues, including Daxin Peng and Zhihao Sun, who contribute to her research efforts.
Conclusion
Sujuan Chen's innovative work in developing a vaccine for the H7N9 subtype avian influenza virus showcases her commitment to public health and scientific advancement. Her contributions are vital in the ongoing fight against avian influenza.